Patents Assigned to ChanRx Corp.
  • Methods for reducing the recurrence of cardiac arrhythmia
    Patent number: 8450325
    Abstract: Disclosed are methods of preventing or treating cardiac arrhythmia comprising administering to a mammal in need thereof, such as a human, an effective amount of vanoxerine (GBR 12909) or a pharmaceutically acceptable salt, derivative or metabolite thereof.
    Type: Grant
    Filed: June 13, 2011
    Date of Patent: May 28, 2013
    Assignees: ChanRx Corp., The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Arthur M. Brown, Naresh Chand